Abstract
Capsular contracture after breast augmentation is a distressing, troublesome event both for the patient and the surgeon. Fibrosis transforms the prosthesis into a hardened sphere, turning the initially satisfactory cosmetic result into a deformed mass. Treatment for capsular contracture can be either surgical, consisting of capsulotomy or capsulectomy with implant replacement, or pharmacologic, consisting of intracapsular instillation of steroids and antibiotics. The success rates for both types of treatment vary. Although capsular contracture is a multifactorial process, one common denominator in the successful treatment of this complication is believed to be the abatement of inflammation. Leukotriene antagonists have emerged recently as effective prophylactic agents for reactive airway diseases. Anecdotal reports have indicated that zafirlukast and montelukast effectively reverse capsular contracture. The authors investigated whether capsular contracture varies significantly over time after zafirlukast therapy by studying 20 women who had breast prostheses implanted and then experienced the development of capsular contracture. The results suggest that capsular contracture responds favorably to treatment with zafirlukast. The findings indicate that zafirlukast may reduce pain and breast capsule distortion for patients with long-standing contracture who either are not surgical candidates or do not wish to undergo surgery.
Similar content being viewed by others
References
Alfano C, Costantini M, Mazzocchi M: Clinical examination and follow-up of mammary implants. Eur Plast Surg Rew 4:4–8, 1999
Alfano C, Mazzocchi M, Scuderi N: Mammary compliance: An objective measurement of capsular contracture. Aesth Plast Surg 28:75–79, 2004
Baker JL: Classification of spherical contractures. Read at the Aesthetic Breast Symposium, Scottsdale, Arizona, 1975
Baker JL: Augmentation mammoplasty. In: Owsley JQ, Peterson R (eds) Symposium on aesthetic surgery of the breast. Mosby: St Louis, pp. 125–152, 1978
Baker JL Jr, Chandler ML, LeVier RR: Occurrence and activity of myofibroblasts in human capsular tissue surrounding mammary implants. Plast Reconstr Surg 68:905–911, 1981
Becker H, Springer R: Prevention of capsular contracture. Plast Reconstr Surg 103:1766–1768, 1999
Burkhardt BR: Comparing contracture rates: Probability theory and the unilateral contracture. Plast Reconstr Surg 74:527–529, 1984
Burkhardt BR: Prevention of capsular contracture. Plast Reconstr Surg 103:1969–1972, 1999
Burkhardt BR, Schhnur PL Tofield JJ, Dempsey PD: An objective clinical assessment of fibrosus capsular contracture. Plast Reconstr Surg 69:794–799, 1982
Caffee HH: Capsule injection for the prevention of contracture. Plast Reconstr Surg 110:1325–1328, 2002
Caffee HH, Rotatori OS: Intracapsular injection of triamcinolone for prevention of contracture. Plast Reconstr Surg 92:1073–1077, 1993
Camirand A, Doucet J, Harris J: Breast augmentation: Compression: A very important factor in preventing capsular contracture. Plast Reconstr Surg 104:529–538, 1999
Clhoun WJ: Summary of clinical trials with zafirlukast. Am J Respir Crit Care Med 157:238–246, 1998
Coleman DJ, Foo IT h, Sharpe DT: Textured or smooth implants for breast augmentation? A prospective controlled trial. Br J Plast Surg 44:444–448, 1991
Collis N, Sharpe D: Recurrence of subglandular breast implant capsular contracture: Anterior versus total capsulectomy. Plast Reconstr Surg 106:792–797, 2000
Danese S, De Vitis I, Gasbarrini A: Severe liver injury associated with zafirlukast. Ann Intern Med 135:930, 2001
Dowden RV, Reisman NR, Corney M: Going off-label with breast implants. Plast Reconstr Surg 110:323–329, 2002
Eisenmann-Klein M: Breast implants: The past, the present, the future. Eur Plast Surg Rew 3:33–43, 1999
Embrey M, Adams EE, Cunningham B, Peters W, Young VL, Carlo GL: A review of the literature on the etiology of capsular contracture and a pilot study to determine the outcome of capsular contracture interventions. Aesth Plast Surg 23:197–206, 1999
Ersek RA: Firestorm fibrosis: The fast fibrotic phenomenon. Ann Plast Surg 20:494–498, 1991
Esaki M, Matsumoto T, Shotaro N, Kawasaki M, Iwai K, Hirakawa K, Tarumi K, Yao T, Iida M: GI involvement in Henoch-Schonlein purpura. Gastrointest Endosc 55:920–923, 2002
Goldstein M, Anoia J, Black M: Montelukast-induced hepatitis. Ann Intern Med 140:586–587, 2004
Gryskiewicz JM: Investigation on Accolate and Singulair for treatment of capsular contracture yields safety concerns. Aesth Surg J 23:98–102, 2003
Gryskiewicz JM: What doctors aren’t being told: Using the freedom of information act. Plast Reconstr Surg 113:743–745, 2003
Hoflehner H, Pierer G: Subjective and objective assessment of capsular contracture. Eur J Plast Surg 17:69–74, 1994
Hoflehner H, Pierer G, Rehak P: Mammary compliance an objective technique for measuring capsular fibrosis. Plast Reconstr Surg 80:1078–1084, 1993
Kelloway JS, Wyett RA, Adlis SA: Comparison of patients’ compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 154:1349–1353, 1994
Kinoshita M, Shiraishi T, Koga T, Ayabe M, Rikimaru T, Oizumi K: Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast. J Allergy Clin Immunol 103:534–535, 1999
Ko CY, Ahn CY, Ko J, Chopra W, Shaw WW: Capsular synovial methaplasia as a common response to both textured and smooth implants. Plast Reconstr Surg 97:1427–1433, 1996
Miller AS III, Tarpley SK, Willard VV, Reynolds GD: Alteration of fibrous capsule formation by the use of immunomodulation. Aesth Surg J 18:346–352, 1998
Mladick RA: Prevention of capsular contracture. Plast Reconstr Surg 1032:1973–1974, 1999
Moufarrege R, Beauregard G, Bosse JP, Papillion J, Perras C: Outcome of mammary capsulotomies. Ann Plast Surg 19:62–64, 1987
Mukhopadhyay A, Stanley NN: Churg-Strauss syndrome associated with montelukast. Postgrad Med J 77:390–391, 2001
Niessen FB, Spauwen PHM: On the nature of hypotrophic scars and keloids: a review. Plast Reconstr Surg 104:1435–1458, 1999
Oda D, Gown Am, Vande Berg JS, Stern R: The fibroblast-like nature of myofibroblast. Exp Mol Pathol 49:316–329, 1988
Perrin ER: The use of soluble steroids within inflatable breast prostheses. Plast Reconstr Surg 54:163–166, 1976
Peterson HD, Burt GB Jr: The role of steroids in prevention of circumferential capsular scaffing in augmentation mammaplasty. Plast Reconstr Surg 54:28–30, 1974
Physicians’ Desk Reference. Accolate tablets (zafirlukast). Medical Economics: Montvale, NJ, pp 657–659, 2002
Physicians’ Desk Reference. Singulair tablets and chewable tablets (montelukast sodium). Medical Economics: Montvale, NJ, pp 2181–2185, 2002
Raso DS, Shlute BA: Immunolocalization of keratan sulfhate, chondroitin-4-sulphate, and chondroitin-6-sulphate in periprosthetic breast capsules exhibiting synovial metaplasia. Plast Reconstr Surg 98:78–82, 1994
Reid RR, Greve SD, Casas LA: The effect of zafirlukast on early capsular contracture in the primary augmentation patient: A pilot study. Aesth Surg J 25:26–32, 2005
Reinus JF, Persky S, Burkiewicz JS, Quan D, Bass NM, Davern TJ: Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast. Ann Intern Med 133:964–968, 2000
Rohirich RJ, Kenkel JM, Adams WP: Preventing capsular contracture in breast augmentation: In search of the Holy Grail. Plast Reconstr Surg 103:1759–1760, 1999
Schlesinger SL, Ellenbogen R, Desvigne MN, Svehlak S, Heck R: Zafirlukast (Accolate): A new treatment for capsular contracture. Aesth Surg. J 22:329–335, 2002
Spear SL, Baker JL Jr: Classification of capsular contracture after prosthetic breast reconstruction. Plast Reconstr Surg 96:1119–1124, 1995
Tang WW, Van GY, Qi M: Myofibroblast and alpha 1 (III) collagen expression in experimental tubolointestinal nephritis. Kidney Int 51:926–931, 1997
Tarpila E, Ghassemifar R, Fagrell D, Berggen A: Capsular contracture with textured versus smooth saline filled implants for breast augmentation: A prospective clinical study. Plast Reconstr Surg 99:1934–1939, 1997
Virchow JC, Prasse A. Naya I, Summerto L, Harris A: Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med 162:578–585, 2000
Vistnes LM, Ksander GA: Tissue response to soft silicone prosthesis: Capsule formation and other sequelae. In: Rubin LR (ed) Biomaterials in reconstructive surgery. Mosby: St. Louis, MO, pp. 516–528, 1983
Wooltorton E: Asthma drug zafirlukast (Accolate): Serious hepatic events. JAMC 170:1668, 2004
Young VL: Guidelines and indications for breast implant capsulectomy. Plast Reconstr Surg 102:884–891, 1998
Acknowledgments
The authors did not receive any financial support for this study, nor were they in any way commercially involved with the companies that manufacture the drug, the mammary compliance device, or the implants.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scuderi, N., Mazzocchi, M., Fioramonti, P. et al. The Effects of Zafirlukast on Capsular Contracture: Preliminary Report. Aesth Plast Surg 30, 513–520 (2006). https://doi.org/10.1007/s00266-006-0038-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-006-0038-3